Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

RIBAVIRIN

RIBAVIRIN

Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview RIBAVIRIN is listed in Drugs@FDA under application 202546 (ANDA).

Marketing status: Discontinued Active ingredient RIBAVIRIN Form and strength TABLET;ORAL - 500MG Sponsor BEXIMCO PHARMS USA Submission history Latest submission status date: 2014-08-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview RIBAVIRIN is listed in Drugs@FDA under application 202546 (ANDA). Marketing status: Discontinued Active ingredient RIBAVIRIN Form and strength TABLET;ORAL - 500MG Sponsor BEXIMCO PHARMS USA Submission history Latest submission status date: 2014-08-12 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.